SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-001214
Filing Date
2023-01-04
Accepted
2023-01-04 07:45:38
Documents
13
Period of Report
2022-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d403064d8k.htm   iXBRL 8-K 47731
  Complete submission text file 0001193125-23-001214.txt   216428

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20221231.xsd EX-101.SCH 3897
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20221231_def.xml EX-101.DEF 14099
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20221231_lab.xml EX-101.LAB 23478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20221231_pre.xml EX-101.PRE 15131
7 EXTRACTED XBRL INSTANCE DOCUMENT d403064d8k_htm.xml XML 6648
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 23504378
SIC: 2834 Pharmaceutical Preparations